Citadel Advisors
MTACU

Citadel Advisors’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

Citadel Advisors’s Portfolio MTACU Stock Details MTACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,622
Closed -$108K – 15133
2021
Q3 		$108K Sell
10,622
-158
-1% -$1.59K ﹤0.01% 12784
2021
Q2 		$108K Buy
+10,780
New +$109K ﹤0.01% 12858
2021
Q1 		– Sell
-552,789
Closed -$5.8M – 13887
2020
Q4 		$5.8M Buy
+552,789
New +$5.77M ﹤0.01% 3430

Other funds holding MTACU

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors's MTACU Position: Q4 2021 in Review

Citadel Advisors sold out of MedTech Acquisition Corporation Unit (MTACU) in Q4 2021, closing a stake of 10,622 shares — an estimated $108K sold.

Citadel Advisors first reported a position in MTACU in Q4 2020 and held it in 3 quarters. The position peaked at $5.8M in Q4 2020. 11 funds tracked by Wall St. Rank hold MTACU as of Q4 2021.

  • Citadel Advisors reported no remaining MedTech Acquisition Corporation Unit position as of Q4 2021 after selling out during the quarter.
  • Citadel Advisors sold 10,622 MedTech Acquisition Corporation Unit shares in Q4 2021, an estimated $108K.
  • Citadel Advisors first reported a position in MedTech Acquisition Corporation Unit in Q4 2020 and held it in 3 quarters.
  • Citadel Advisors's MedTech Acquisition Corporation Unit position peaked at $5.8M in Q4 2020.
  • 11 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q4 2021.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.